Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00792285 · ClinicalTrials.gov registry record · NA
RCT of Automated Telephone Outreach to Improve Colorectal Cancer Screening
A NA study, sponsored by Harvard Pilgrim Health Care.
- Completed
- Registry status
- NA
- Development phase
- 80,000
- Enrollment target
NCT00792285 is a NA study that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 80,000 participants.
The verdict
NCT00792285, a NA study, has completed, sponsored by Harvard Pilgrim Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 80,000 participants
- Enrollment target
Study Summary
This large randomized controlled trial is testing the effectiveness of automated telephone outreach with speech recognition to improve rates of screening for colorectal cancer. The hypothesis is that the intervention improves rates of screening overall and specifically rates of colonoscopy.
Interventions
- BEHAVIORAL Automated Telephone Outreach with Speech Recognition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80,000 participants |
| Start Date | 2005-03 |
| Est. Completion | 2006-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00792285
The ClinicalTrials.gov registry entry for NCT00792285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard Pilgrim Health Care, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Automated Telephone Outreach with Speech Recognition is the first listed.
NCT00792285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00792285 about?
NCT00792285 is a clinical study titled "RCT of Automated Telephone Outreach to Improve Colorectal Cancer Screening". This large randomized controlled trial is testing the effectiveness of automated telephone outreach with speech recognition to improve rates of screening for colorectal cancer. The hypothesis is that the intervention improves rates of screening overall and specifically rates of colonoscopy.
What is the current status of trial NCT00792285?
This trial is currently completed. It is a NA study. The enrollment target is 80,000 participants. The study started on 2005-03. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00792285?
The interventions under investigation include: Automated Telephone Outreach with Speech Recognition (BEHAVIORAL).
Who is sponsoring clinical trial NCT00792285?
This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.